Making the full scale of the proteome accessible to all labs
Understanding of the full depth and breadth of the proteome is required for true breakthroughs in basic biology, medicine, biotechnology, and more. We are developing a solution with the sensitivity, dynamic range, and ease of use necessary to make the vast scale and value of the proteome accessible to all researchers.
Driving breakthroughs across all of biology
Applications of our platform
A solution that matches the scale of the proteome
Dive deeper into the science behind our platform and its applications
Proteomics at scale: Current approaches and emerging technologies
We outline the primary advantages and challenges of current proteomics technologies and discuss measures needed to enable quantification of the proteome at depths substantially greater than the 8-30% of the proteome that is readily accessible today.
Proteomics and cancer
Learn how proteomics is advancing cancer research and may usher in the creation of new cancer diagnostics and treatments.
Proteomics and neuroscience
Learn how proteomics is advancing the study of the brain and broader nervous system and how next-generation proteomics can accelerate basic and applied neuroscience.
White paper series: The proteomics revolution
This post contains white papers describing how developments in proteomics - led by the Nautilus platform - will improve healthcare.
Single-Molecule Proteomics using Protein Identification by Short-epitope Mapping
The field of proteomics is poised for a single-molecule revolution – enabling more comprehensive analysis of the proteins in a sample with increased sensitivity, reproducibility, and accessibility.
Podcast, video, and interview round-up featuring the Nautilus Founders
Sujal Patel and Parag Mallick founded Nautilus Biotechnology to revolutionize biomedicine by unlocking the power of the proteome. As the Nautilus platform shifts from a theoretical idea to a commercial product, learn how the founders...